Predicting responsiveness to fampridine in gait-impaired patients with multiple sclerosis.
Linard FilliJ WernerG BeyerK ReuterJ A PetersenM WellerB ZörnerM LinnebankPublished in: European journal of neurology (2018)
Initial walking impairment is a good predictor of therapeutic responsiveness to PR-fampridine. Valid predictors of patients' responsiveness to PR-fampridine are essential for patient stratification and optimization of multiple slcerosis treatment.